Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
about
Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetesPrimary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectivesDiet, Microbiota and Immune System in Type 1 Diabetes Development and EvolutionEvaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay ValidationNew approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunityThe development, validation, and utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS).Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus reportDisease modifying therapies in type 1 diabetes: Where have we been, and where are we going?Molecular Interactions Governing Autoantigen Presentation in Type 1 DiabetesType 1 diabetes through the life span: a position statement of the American Diabetes AssociationEnvironmental risk factors for type 1 diabetesA rapid lateral flow immunoassay for the detection of tyrosine phosphatase-like protein IA-2 autoantibodies in human serumCapillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da studyType 1 diabetes mellitus.Type 1 diabetes: a disease of developmental origins.Genetics and its potential to improve type 1 diabetes care.A 3D map of the islet routes throughout the healthy human pancreas.HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease ProgressionAutoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of diseaseA type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.Risk of type 1 diabetes progression in islet autoantibody-positive children can be further stratified using expression patterns of multiple genes implicated in peripheral blood lymphocyte activation and function.Early hyperglycemia detected by continuous glucose monitoring in children at risk for type 1 diabetes.Early prediction of autoimmune (type 1) diabetes.Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity.Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes.A complex role of herpes viruses in the disease process of multiple sclerosis.Characteristics and determinants of partial remission in children with type 1 diabetes using the insulin-dose-adjusted A1C definitionHydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.Novel diagnostic and therapeutic approaches for autoimmune diabetes--a prime time to treat insulitis as a disease.Role of viruses and other microbes in the pathogenesis of type 1 diabetes.Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients.The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY studyRegulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.Type 1 diabetes: A predictable disease.Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.Reliable diagnosis of murine type 1 diabetes using a panel of autoantigens and "antigen surrogates" mounted onto a liquid array.Thrombophilia Associated with Anti-DFS70 Autoantibodies.
P2860
Q21260349-90BEDBBF-63FE-4E12-8FE9-1445969DF53BQ26748984-47705022-1AD0-46DB-9DA4-E9C57376DB4AQ26777399-E777A14E-591D-4A39-A4F6-A4DD7D31D994Q26783728-63E60F83-AEFF-4818-ACCC-D93635FAF8FCQ26800973-D94A5A92-85A1-4F7A-A219-A969A1ED721DQ27346599-493FDD81-E424-49B0-86CD-70D8435079AFQ27687598-ABAD82C9-54DC-48BF-8317-9D0413C3B89FQ28081034-22A8F70D-33D9-44AD-A5C1-E1C3BDAB77BCQ28084487-E9678681-3076-4913-9469-8BDCDF8D94A4Q28242092-072748E7-7844-4C16-B71D-3A03E4F5764CQ28276366-61A56A6E-DDF9-42DB-8ECD-97BCB4AA3514Q28390646-41DB94C1-A41D-4EE8-A34D-D366DF691CFDQ28602447-68E14AB5-D6C1-4F04-B43E-6BFA9999F675Q30235021-5A2FE196-5D04-4E80-82E1-E0CA2BCFEB2BQ30248490-B4577B8B-2944-46B8-AD7F-78EFCDF93881Q30252400-92F5CFCF-E6D0-4C57-969E-542379673373Q30666066-8736CC22-BA76-40BB-BC22-305ED05DDBB3Q30732418-034234FE-7B26-43F9-940F-4EE31B31308CQ33729769-70CEDA61-8A0F-4695-8743-E988C9D6D8ECQ33789317-30921F85-F410-4143-9D63-5A52688FEB9BQ33789346-E285EB6F-DE92-4234-ADCD-A8FF088F2B2DQ33793829-E58D3C65-6D6D-4A03-B0DE-EB205712C812Q33854613-D5D965DA-D747-43EE-B89B-D2511479D232Q33916508-968288E5-4EAB-4D1C-9860-6C4F924B7FB9Q34065354-3F7B2455-E6A7-4592-A820-199441FE1754Q34078589-643EB25B-1094-4AC4-8C69-34BDC60D9C78Q34181376-72475C49-FD45-48CB-BE6C-1C00BD09391CQ34477816-6387E1A9-A15D-4169-A720-D0141D1B1DF6Q34604619-F377C25F-9918-47B9-B00D-487CDBF7516BQ35064081-141DD39B-0DDE-4801-98AD-5969BC1DC61BQ35108159-9BE18358-C06E-4857-B322-7FA5707E4432Q35115373-3CAFD646-BE54-4195-A49A-608AF533F1AAQ35128879-1CA5FFB5-DBF1-439A-934B-B92D47C921E5Q35371094-60C8AE7C-1916-4588-BA9C-0DF9D6F72318Q35378628-57E8DDE0-CDA2-41B7-89D7-B4CC5AC25248Q35437721-3EECED15-7447-44A9-A6D6-2B9FDF6D66FDQ35531906-178E74E5-10BE-4B2B-AB18-2E810AC7CC0AQ35557877-538FCAE9-1252-45E8-AB62-551A4BF601CDQ35782179-08B09728-4E79-417A-9110-CCAA152A1690Q35784744-D51CC045-6FAC-49F4-83BA-EF007081F9BB
P2860
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Seroconversion to multiple isl ...... ssion to diabetes in children.
@en
type
label
Seroconversion to multiple isl ...... ssion to diabetes in children.
@en
prefLabel
Seroconversion to multiple isl ...... ssion to diabetes in children.
@en
P2093
P2860
P50
P356
P1476
Seroconversion to multiple isl ...... ssion to diabetes in children.
@en
P2093
Andrea Steck
Anette G Ziegler
Christiane Winkler
George S Eisenbarth
Johanna Lempainen
Olli Simell
Tuula Simell
P2860
P304
P356
10.1001/JAMA.2013.6285
P407
P577
2013-06-01T00:00:00Z